MRI Tumor Regression Response to Neoadjuvant Chemotherapy Alone without Radiation for Rectal Adenocarcinoma

医学 化疗 新辅助治疗 腺癌 肿瘤科 放射治疗 完全响应 结直肠癌 放射科 直肠癌 内科学 癌症 乳腺癌
作者
Yu Shen,Xiaoling Gong,Yazhou He,Wenjian Meng,Hanjiang Zeng,Mingtian Wei,Meng Qiu,Ziqiang Wang,Shannyn Wolfe
出处
期刊:Radiology [Radiological Society of North America]
卷期号:312 (2) 被引量:1
标识
DOI:10.1148/radiol.232908
摘要

Background Neoadjuvant chemotherapy (NCT) is gaining acceptance for the management of locally advanced rectal cancer (LARC) in patients without negative prognostic factors. However, the value of MRI in evaluating tumor response after NCT remains unclear. Purpose To investigate the accuracy of MRI in assessing pathologic complete response in participants with LARC who underwent surgery after NCT without radiation. Materials and Methods A retrospective imaging substudy was conducted within two consecutive prospective clinical trials: the expanded phase II trial (from December 2017 to May 2021) and the COPEC trial (comparison of tumor response to two or four cycles of neoadjuvant chemotherapy alone, ongoing from August 2021). All included participants received four cycles of capecitabine combined with oxaliplatin (or CAPOX) before surgery. Three radiologists who were blinded to the clinicopathologic data independently evaluated the tumor response using five methods, namely, MR tumor regression grade (MR-TRG) alone, diffusion-weighted imaging (DWI) alone, DWI-modified MR-TRG (DWImodMR-TRG), MRI complete response, and radiologic neoadjuvant response score. With pathologic assessment serving as the reference standard, the positive and negative predictive values, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were determined to evaluate the accuracy and performance of these models. The AUCs of the models were compared using the DeLong test. Results A total of 224 participants were included, comprising 119 from the expanded phase II trial (median age, 61 years [IQR, 53-67]; 89 male) and 105 from the COPEC trial (median age, 59 years [IQR, 53-67]; 65 male). MR-TRG, DWI, DWImodMR-TRG, MRI complete response, and the radiologic neoadjuvant response score were associated with pathologic complete response. DWImodMR-TRG achieved the highest AUC of 0.90 (95% CI: 0.85, 0.95), with a specificity of 89% (162 of 182) and a negative predictive value of 93% (162 of 174). Conclusion MRI-based models were accurate for determining pathologic complete response in participants with LARC following NCT. DWI improved the predictive performance of MRI-based assessment. © RSNA, 2024
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小宁软糖发布了新的文献求助10
1秒前
xixi发布了新的文献求助30
1秒前
vovoking完成签到 ,获得积分10
1秒前
2秒前
发嗲的高跟鞋完成签到,获得积分10
2秒前
张宁波完成签到,获得积分10
3秒前
香蕉觅云应助聂学雨采纳,获得10
4秒前
耳东陈完成签到 ,获得积分10
4秒前
潇洒的诗桃完成签到,获得积分0
4秒前
顾矜应助贤惠的面包采纳,获得10
4秒前
吼吼哈哈完成签到,获得积分10
5秒前
angew2000发布了新的文献求助10
5秒前
5秒前
李金玉发布了新的文献求助20
6秒前
6秒前
7秒前
peach发布了新的文献求助10
8秒前
wanzhen完成签到,获得积分10
8秒前
8秒前
酷波er应助KSung采纳,获得10
9秒前
yue关闭了yue文献求助
9秒前
嗷嗷完成签到,获得积分20
9秒前
燕子发布了新的文献求助10
9秒前
Tammy完成签到 ,获得积分10
10秒前
lzq完成签到 ,获得积分10
10秒前
renzhiqiang发布了新的文献求助10
10秒前
10秒前
闪闪龙猫完成签到,获得积分20
10秒前
丰富成败完成签到,获得积分10
10秒前
hcmsaobang2001完成签到,获得积分10
11秒前
11秒前
XXX发布了新的文献求助10
11秒前
马一凡完成签到,获得积分10
11秒前
11秒前
ZZXX完成签到,获得积分10
12秒前
粗心的飞槐完成签到 ,获得积分10
12秒前
13秒前
咖啡豆应助Hans采纳,获得20
13秒前
典雅的夜安完成签到,获得积分10
13秒前
科目三应助lele采纳,获得10
14秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3147351
求助须知:如何正确求助?哪些是违规求助? 2798580
关于积分的说明 7829767
捐赠科研通 2455324
什么是DOI,文献DOI怎么找? 1306666
科研通“疑难数据库(出版商)”最低求助积分说明 627883
版权声明 601567